Bioharvest Sciences (BHST) Operating Expenses (2023 - 2025)

Bioharvest Sciences' Operating Expenses history runs 3 years deep, the most recent figure standing at $45.8 million for Q4 2025.

• On a quarterly basis, Operating Expenses rose 26.92% year-over-year to $45.8 million in Q4 2025; TTM through Dec 2025 was $26.1 million, a 24.46% increase from a year earlier, with the FY2025 full-year figure at $26.1 million, up 24.46% from the prior year.
• Operating Expenses grew to $45.8 million in Q4 2025 per BHST's latest filing, from -$6.5 million in the prior quarter.
• Across five years, Operating Expenses topped out at $45.8 million in Q4 2025 and bottomed at -$26.4 million in Q4 2023.
• The 3-year median for Operating Expenses is -$4.9 million (2024), against an average of $2.6 million.
• Biggest YoY gain for Operating Expenses was 236.79% in 2024; the steepest drop was 268.63% in 2024.
• Year by year, Operating Expenses stood at -$26.4 million in 2023, then jumped by 236.79% to $36.1 million in 2024, then grew by 26.92% to $45.8 million in 2025.
• Per Business Quant, the three latest BHST Operating Expenses figures stand at $45.8 million (Q4 2025), -$6.5 million (Q3 2025), and -$6.9 million (Q2 2025).